[Hormone therapy, cardio-metabolic profile, and cardiotoxicity. Still a dark side of cardio-oncology - Part 2: Prostate cancer]. / Terapia ormonale, assetto cardio-metabolico e cardiotossicità. Il lato ancora oscuro della cardioncologia Parte 2: Tumore della prostata.
G Ital Cardiol (Rome)
; 24(10): 781-791, 2023 Oct.
Article
in It
| MEDLINE
| ID: mdl-37767830
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostatic Neoplasms
/
Cardiovascular Diseases
/
Neoplasms
/
Antineoplastic Agents
Type of study:
Guideline
/
Risk_factors_studies
Limits:
Humans
/
Male
Language:
It
Journal:
G Ital Cardiol (Rome)
Journal subject:
CARDIOLOGIA
Year:
2023
Document type:
Article
Country of publication:
Italia